Completely-in-the-Canal and Bone Anchored Hearing Aids: A Review of the Clinical Effectiveness and Cost-Effectiveness
Canadian Agency for Drugs and Technologies in Health. (2010).
Ottawa (Canada): Canadian Agency for Drugs and Technologies in Health, 1-15.
This review investigates clinical effectiveness and cost-effectiveness of bone-anchored hearing aids (BAHA) and completely-in-the-canal (CIC) hearing aids in adults (less than 60-years-old) with sensorineural hearing loss.
Canadian Agency for Drugs and Technologies in Health
2005-February 2010
Published, English-language studies (not further specified)
5 (BAHA); 0 (CIC)
There was limited evidence, mainly from observational studies, regarding the acoustic and non-acoustic benefits of [bone-anchored hearing aids]. The authors of a previous Health Technology Assessment (2006) considered the [bone-anchored hearing aid] to be experimental for unilateral sensorineural hearing loss, bilateral implantation, and tinnitus and advised caution when discussing treatment options with patients.
"No evidence was identified for [completely-in-the-canal] hearing aids" (p. 6).
